» Articles » PMID: 4564560

Infection-immunity in Tularemia: Specificity of Cellular Immunity

Overview
Journal Infect Immun
Date 1972 Mar 1
PMID 4564560
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

The relationship between hypersensitivity and cellular resistance to infection with facultative intracellular parasites was studied in mice by using infection-immunity in tularemia as a model system. Delayed hypersensitivity to antigenic fractions of Francisella tularensis was first detected 6 to 7 days after immunization with viable F. tularensis vaccine, at which time immunity against challenge infection developed. Both immunity and delayed-type sensitivity reached maximal levels by 9 to 10 days. Immediate hypersensitivity occurred after immunization with both viable and nonviable tularemia vaccines but could not be correlated with resistance since nonviable antigens were not protective. Attempts to relate resistance to F. tularensis with nonspecific immunity factors were unsuccessful. Immunization of mice with BCG vaccine stimulated protection against infection with F. novicida and Salmonella typhimurium but provided no protection against infection with F. tularensis. Moreover, viable tularemia vaccine, while inducing marked protection against challenge with specific organisms, afforded no protection against infection with S. typhimurium or S. enteritidis. It is concluded that cellular immunity in tularemia involves an immunologically specific component.

Citing Articles

Early infection-induced natural antibody response.

Kubelkova K, Hudcovic T, Kozakova H, Pejchal J, Macela A Sci Rep. 2021; 11(1):1541.

PMID: 33452341 PMC: 7810682. DOI: 10.1038/s41598-021-81083-0.


Immunotherapy for tularemia.

Skyberg J Virulence. 2013; 4(8):859-70.

PMID: 23959031 PMC: 3925717. DOI: 10.4161/viru.25454.


Long lived protection against pneumonic tularemia is correlated with cellular immunity in peripheral, not pulmonary, organs.

Anderson R, Crane D, Bosio C Vaccine. 2010; 28(40):6562-72.

PMID: 20688042 PMC: 2939155. DOI: 10.1016/j.vaccine.2010.07.072.


Differential requirements for protection against mucosal challenge with Francisella tularensis in the presence versus absence of cholera toxin B and inactivated F. tularensis.

Bitsaktsis C, Rawool D, Li Y, Kurkure N, Iglesias B, Gosselin E J Immunol. 2009; 182(8):4899-909.

PMID: 19342669 PMC: 2720832. DOI: 10.4049/jimmunol.0803242.


Purified lipopolysaccharide from Francisella tularensis live vaccine strain (LVS) induces protective immunity against LVS infection that requires B cells and gamma interferon.

Dreisbach V, Cowley S, Elkins K Infect Immun. 2000; 68(4):1988-96.

PMID: 10722593 PMC: 97377. DOI: 10.1128/IAI.68.4.1988-1996.2000.


References
1.
NUTTER J, Myrvik Q . In vitro interactions between rabbit alveolar macrophages and Pasteurella tularensis. J Bacteriol. 1966; 92(3):645-51. PMC: 276304. DOI: 10.1128/jb.92.3.645-651.1966. View

2.
Mackaness G, Blanden R . Cellular immunity. Prog Allergy. 1967; 11:89-140. View

3.
Dannenberg Jr A . Cellular hypersensitivity and cellular immunity in the pathogensis of tuberculosis: specificity, systemic and local nature, and associated macrophage enzymes. Bacteriol Rev. 1968; 32(2):85-102. PMC: 378299. DOI: 10.1128/br.32.2.85-102.1968. View

4.
Brehmer W, Anacker R, Ribi E . Immunogenicity of cell walls from various mycobacteria against airborne tuberculosis in mice. J Bacteriol. 1968; 95(6):2000-4. PMC: 315125. DOI: 10.1128/jb.95.6.2000-2004.1968. View

5.
Collins F . Recall of immunity in mice vaccinated with Salmonella enteritidis or Salmonella typhimurium. J Bacteriol. 1968; 95(6):2014-21. PMC: 315128. DOI: 10.1128/jb.95.6.2014-2021.1968. View